Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(33.3%)
Phase 4
1(33.3%)
N/A
1(33.3%)
3Total
Phase 3(1)
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01329588Phase 4Completed

Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers

Role: collaborator

NCT00970879Phase 3Completed

Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine

Role: collaborator

NCT00510679Not ApplicableCompleted

Study of Post-Training Supports for Health Workers in Benin

Role: collaborator

All 3 trials loaded